Related Experiment Videos
Opsoclonus-myoclonus associated with celiac disease
Nicolas Deconinck1, Michèle Scaillon, Valérie Segers
1Department of Neurology, Hôpital Universitaire des Enfants Reine Fabiola, Université Libre de Bruxelles (ULB), Brussels, Belgium. nicolas.deconinck@huderf.be
Pediatric Neurology
|April 28, 2006
Summary
Celiac disease can present with neurological symptoms like opsoclonus-myoclonus syndrome in children. Early evaluation for celiac disease is crucial in cases of unexplained opsoclonus-myoclonus.
Area of Science:
- Neurology
- Gastroenterology
- Immunology
Background:
- Celiac disease is an autoimmune disorder triggered by gluten ingestion.
- Neurologic manifestations are increasingly recognized in celiac disease, with cerebellar ataxia being the most common.
- Opsoclonus-myoclonus syndrome (OMS) is a rare autoimmune disorder characterized by chaotic eye movements and myoclonic jerks.
Observation:
- A 2-year-old male presented with severe opsoclonus-myoclonus syndrome, including ataxia, rendering him unable to sit or walk.
- Initial investigations, including brain MRI and infectious serology, were unremarkable.
- Cerebrospinal fluid showed oligoclonal bands, while blood autoantibody testing revealed antigliadin and anti-endomysial antibodies.
Findings:
- Duodenal biopsy confirmed villous atrophy, establishing the diagnosis of celiac disease.
- The patient's neurological symptoms were attributed to celiac disease, despite normal initial blood work and negative cerebrospinal fluid autoantibodies.
- This case highlights that celiac disease can manifest primarily with neurological symptoms.
Implications:
- The findings suggest that celiac disease should be considered in the differential diagnosis of pediatric opsoclonus-myoclonus syndrome.
- Routine screening for celiac disease, including autoantibody testing and duodenal biopsy, may be warranted in children presenting with unexplained neurological disorders.
- Early diagnosis and treatment of celiac disease can potentially improve neurological outcomes.